Since 2015, I have been working on microfluidics devices for purifying industrially-generated blood.
There is a massive unmet and increasing clinical demand for blood – in the UK alone 2.2 million units of blood are used each year at a cost of around £140 per unit.
The industrial generation of blood would end current problems in maintaining supply of blood for transfusion, managing the risk of infection and ensuring compatibility between donor and recipient.
- High-throughput assessment of mechanical properties of stem cell derived red blood cells, toward cellular downstream processing. E. Guzniczak, M. Mohammad Zadeh, F. Dempsey, M. Jimenez, H. Bock, G. Whyte, N. Willoughby and H. Bridle. Scientific Reports 7, Article number: 14457 (2017)